Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.39 Billion USD | 6.55% |
| 2022 | 6.93 Billion USD | 1.65% |
| 2021 | 6.82 Billion USD | -2.81% |
| 2020 | 7.02 Billion USD | -12.0% |
| 2019 | 7.98 Billion USD | 0.62% |
| 2018 | 7.93 Billion USD | 1.39% |
| 2017 | 7.82 Billion USD | 1.82% |
| 2016 | 7.68 Billion USD | 28.11% |
| 2015 | 5.99 Billion USD | 28.34% |
| 2014 | 4.67 Billion USD | 1.08% |
| 2013 | 4.62 Billion USD | 3.39% |
| 2012 | 4.47 Billion USD | 0.45% |
| 2011 | 4.45 Billion USD | 5.49% |
| 2010 | 4.22 Billion USD | 3.05% |
| 2009 | 4.09 Billion USD | -0.62% |
| 2008 | 4.12 Billion USD | 5.74% |
| 2007 | 3.89 Billion USD | 11.5% |
| 2006 | 3.49 Billion USD | 6.37% |
| 2005 | 3.28 Billion USD | 10.24% |
| 2004 | 2.98 Billion USD | 56.81% |
| 2003 | 1.9 Billion USD | 38.52% |
| 2002 | 1.37 Billion USD | 16.44% |
| 2001 | 1.17 Billion USD | 13.26% |
| 2000 | 1.04 Billion USD | 10.82% |
| 1999 | 939 Million USD | 9.06% |
| 1998 | 861 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.94 Billion USD | 2.79% |
| 2024 Q3 | 1.82 Billion USD | -6.07% |
| 2024 Q1 | 1.88 Billion USD | -2.62% |
| 2023 Q4 | 1.94 Billion USD | 10.64% |
| 2023 Q2 | 1.86 Billion USD | 2.11% |
| 2023 Q1 | 1.83 Billion USD | 0.32% |
| 2023 Q3 | 1.75 Billion USD | -6.2% |
| 2023 FY | 7.39 Billion USD | 6.55% |
| 2022 FY | 6.93 Billion USD | 1.65% |
| 2022 Q2 | 1.78 Billion USD | 7.13% |
| 2022 Q1 | 1.66 Billion USD | -6.41% |
| 2022 Q3 | 1.66 Billion USD | -6.29% |
| 2022 Q4 | 1.82 Billion USD | 9.3% |
| 2021 Q2 | 2.02 Billion USD | 9.72% |
| 2021 Q3 | 1.92 Billion USD | -5.08% |
| 2021 Q1 | 1.84 Billion USD | -11.41% |
| 2021 Q4 | 1.77 Billion USD | -7.63% |
| 2021 FY | 6.82 Billion USD | -2.81% |
| 2020 Q3 | 1.92 Billion USD | 57.35% |
| 2020 Q1 | 1.78 Billion USD | -16.08% |
| 2020 Q2 | 1.22 Billion USD | -31.26% |
| 2020 Q4 | 2.08 Billion USD | 8.09% |
| 2020 FY | 7.02 Billion USD | -12.0% |
| 2019 FY | 7.98 Billion USD | 0.62% |
| 2019 Q1 | 1.97 Billion USD | -4.61% |
| 2019 Q2 | 1.98 Billion USD | 0.66% |
| 2019 Q3 | 1.89 Billion USD | -4.84% |
| 2019 Q4 | 2.12 Billion USD | 12.33% |
| 2018 Q4 | 2.07 Billion USD | 12.76% |
| 2018 FY | 7.93 Billion USD | 1.39% |
| 2018 Q1 | 2.01 Billion USD | -2.73% |
| 2018 Q2 | 2 Billion USD | -0.5% |
| 2018 Q3 | 1.83 Billion USD | -8.51% |
| 2017 Q2 | 1.95 Billion USD | -1.16% |
| 2017 FY | 7.82 Billion USD | 1.82% |
| 2017 Q4 | 2.07 Billion USD | 14.09% |
| 2017 Q3 | 1.81 Billion USD | -6.97% |
| 2017 Q1 | 1.97 Billion USD | -1.78% |
| 2016 Q2 | 1.93 Billion USD | 1.58% |
| 2016 Q3 | 1.83 Billion USD | -5.23% |
| 2016 Q4 | 2.01 Billion USD | 9.84% |
| 2016 FY | 7.68 Billion USD | 28.11% |
| 2016 Q1 | 1.9 Billion USD | -1.53% |
| 2015 Q4 | 1.93 Billion USD | 9.73% |
| 2015 Q1 | 1.13 Billion USD | -7.24% |
| 2015 Q3 | 1.76 Billion USD | 50.92% |
| 2015 FY | 5.99 Billion USD | 28.34% |
| 2015 Q2 | 1.16 Billion USD | 2.93% |
| 2014 Q4 | 1.22 Billion USD | 10.57% |
| 2014 FY | 4.67 Billion USD | 1.08% |
| 2014 Q3 | 1.1 Billion USD | -6.5% |
| 2014 Q2 | 1.18 Billion USD | 1.84% |
| 2014 Q1 | 1.16 Billion USD | -6.38% |
| 2013 Q2 | 1.16 Billion USD | 2.69% |
| 2013 Q1 | 1.13 Billion USD | -3.52% |
| 2013 Q4 | 1.24 Billion USD | 15.49% |
| 2013 Q3 | 1.07 Billion USD | -8.14% |
| 2013 FY | 4.62 Billion USD | 3.39% |
| 2012 FY | 4.47 Billion USD | 0.45% |
| 2012 Q3 | 1.02 Billion USD | -8.84% |
| 2012 Q2 | 1.12 Billion USD | -1.38% |
| 2012 Q1 | 1.14 Billion USD | -2.28% |
| 2012 Q4 | 1.18 Billion USD | 15.11% |
| 2011 Q1 | 1.11 Billion USD | -1.68% |
| 2011 FY | 4.45 Billion USD | 5.49% |
| 2011 Q4 | 1.16 Billion USD | 13.17% |
| 2011 Q3 | 1.03 Billion USD | -9.31% |
| 2011 Q2 | 1.13 Billion USD | 1.95% |
| 2010 Q3 | 965 Million USD | -8.76% |
| 2010 Q1 | 1.06 Billion USD | -4.02% |
| 2010 Q2 | 1.05 Billion USD | -0.48% |
| 2010 FY | 4.22 Billion USD | 3.05% |
| 2010 Q4 | 1.13 Billion USD | 17.59% |
| 2009 Q1 | 992.6 Million USD | -3.65% |
| 2009 FY | 4.09 Billion USD | -0.62% |
| 2009 Q4 | 1.1 Billion USD | 13.5% |
| 2009 Q3 | 975.6 Million USD | -4.34% |
| 2009 Q2 | 1.01 Billion USD | 2.75% |
| 2008 Q1 | 1.05 Billion USD | -1.33% |
| 2008 Q2 | 1.07 Billion USD | 1.92% |
| 2008 Q4 | 1.03 Billion USD | 8.19% |
| 2008 Q3 | 952.2 Million USD | -11.79% |
| 2008 FY | 4.12 Billion USD | 5.74% |
| 2007 Q2 | 970.6 Million USD | 2.15% |
| 2007 Q3 | 903.2 Million USD | -6.94% |
| 2007 FY | 3.89 Billion USD | 11.5% |
| 2007 Q1 | 950.2 Million USD | 1.78% |
| 2007 Q4 | 1.07 Billion USD | 18.86% |
| 2006 Q4 | 933.6 Million USD | 13.88% |
| 2006 FY | 3.49 Billion USD | 6.37% |
| 2006 Q3 | 819.8 Million USD | -7.01% |
| 2006 Q1 | 860.4 Million USD | 1.43% |
| 2006 Q2 | 881.6 Million USD | 2.46% |
| 2005 FY | 3.28 Billion USD | 10.24% |
| 2005 Q1 | 828.5 Million USD | 3.42% |
| 2005 Q2 | 846.8 Million USD | 2.21% |
| 2005 Q3 | 762.5 Million USD | -9.96% |
| 2005 Q4 | 848.3 Million USD | 11.25% |
| 2004 Q1 | 742.2 Million USD | 5.79% |
| 2004 Q3 | 700.2 Million USD | -5.04% |
| 2004 Q2 | 737.4 Million USD | -0.65% |
| 2004 FY | 2.98 Billion USD | 56.81% |
| 2004 Q4 | 801.1 Million USD | 14.41% |
| 2003 Q2 | 411.1 Million USD | 5.38% |
| 2003 FY | 1.9 Billion USD | 38.52% |
| 2003 Q3 | 398.2 Million USD | -3.14% |
| 2003 Q1 | 390.1 Million USD | 5.38% |
| 2003 Q4 | 701.6 Million USD | 76.19% |
| 2002 Q4 | 370.2 Million USD | 9.69% |
| 2002 FY | 1.37 Billion USD | 16.44% |
| 2002 Q1 | 319.1 Million USD | 2.41% |
| 2002 Q2 | 345.6 Million USD | 8.3% |
| 2002 Q3 | 337.5 Million USD | -2.34% |
| 2001 Q3 | 286.7 Million USD | -2.58% |
| 2001 FY | 1.17 Billion USD | 13.26% |
| 2001 Q2 | 294.3 Million USD | 2.9% |
| 2001 Q1 | 286 Million USD | 4.08% |
| 2001 Q4 | 311.6 Million USD | 8.69% |
| 2000 Q2 | 260.9 Million USD | 2.92% |
| 2000 Q1 | 253.5 Million USD | 0.0% |
| 2000 FY | 1.04 Billion USD | 10.82% |
| 2000 Q4 | 274.8 Million USD | 9.13% |
| 2000 Q3 | 251.8 Million USD | -3.49% |
| 1999 FY | 939 Million USD | 9.06% |
| 1998 FY | 861 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 81.565% |
| Allurion Technologies Inc. | 53.46 Million USD | -13729.465% |
| Artivion, Inc. | 354 Million USD | -1988.733% |
| Avanos Medical, Inc. | 673.3 Million USD | -998.203% |
| Butterfly Network, Inc. | 65.9 Million USD | -11120.334% |
| Butterfly Network, Inc. | 65.9 Million USD | -11120.334% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -176.805% |
| Boston Scientific Corporation | 14.24 Billion USD | 48.074% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -103985.023% |
| CONMED Corporation | 1.24 Billion USD | -495.848% |
| Edwards Lifesciences Corporation | 6 Billion USD | -23.138% |
| Paragon 28, Inc. | 216.38 Million USD | -3317.087% |
| Glaukos Corporation | 314.71 Million USD | -2249.521% |
| Globus Medical, Inc. | 1.56 Billion USD | -371.426% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -1083.453% |
| Integer Holdings Corporation | 1.59 Billion USD | -363.1% |
| Medtronic plc | 32.36 Billion USD | 77.153% |
| Nevro Corp. | 425.17 Million USD | -1639.1% |
| Owlet, Inc. | 54.01 Million USD | -13590.428% |
| Penumbra, Inc. | 1.05 Billion USD | -598.54% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | -33.253% |
| Sonendo, Inc. | 43.86 Million USD | -16756.719% |
| STERIS plc | 5.13 Billion USD | -43.892% |
| Stryker Corporation | 20.49 Billion USD | 63.927% |
| Vapotherm, Inc. | 68.66 Million USD | -10667.887% |